Tag: Blood Glucose Monitors
Glycated Hemoglobin Lower With Continuous Glucose Monitoring in T1DM
Glycated hemoglobin levels lower and time spent in glucose target range greater with use of intermittently scanned CGM versus fingerstick testing
Factory-Calibrated CGM Seems Accurate for Hemodialysis Patients
Performance of a factory-calibrated continuous glucose monitor evaluated in outpatients receiving intermittent hemodialysis
Early Glycemic Control May Cut CV Risk in Type 2 Diabetes
Greater glycemic variability is associated with increased risk for major adverse cardiovascular events
NAFLD May Raise Risk for Severe Hypoglycemia in T2DM
Association independent of obesity status seen in patients with type 2 diabetes and nonalcoholic fatty liver disease
Model Using Routine Clinical Data May Predict Pancreatic Cancer Risk
Findings show promise following diagnosis of impaired fasting glucose
Model Using Routine Clinical Data May Predict Pancreatic Cancer Risk
Findings show promise following diagnosis of impaired fasting glucose
High Endogenous Melatonin Impairs Glucose Tolerance
Lower insulin area under the curve and higher glucose area under the curve observed with late dinner timing
Add-On PPI Therapy May Improve Glycemic Control in Diabetes
However, treatment with proton pump inhibitors is not associated with risk for incident diabetes in the general population
Greater HbA1c Variability May Raise Risk for CVD in T2DM
Severe hypoglycemia may mediate this association
Hyperglycemia, Hypoglycemia Linked to Poor Outcomes in COVID-19
Admission blood glucose is strong predictor of death among patients admitted directly to the ICU
